Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Adeno-Associated Viral Vector Mediated Expression of Broadly- Neutralizing Antibodies Against HIV-Hitting a Fast-Moving Target.

Current HIV research - 1 Jan 2020

Sherpa Chringma, Le Grice Stuart F J

Abstract excerpt

The vast genetic variability of HIV has impeded efforts towards a cure for HIV. Lifelong administration of combined antiretroviral therapy (cART) is highly effective against HIV and has markedly increased the life expectancy of HIV infected individuals. However, the long-term usage of cART is associated with co-morbidities and the emergence of multidrug-resistant escape mutants necessitating the development of...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to AIDS Vaccines
Share to Anti-Retroviral Agents
Share to Broadly Neutralizing Antibodies

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Dependovirus

Share to Genetic Therapy

Share to HIV Antibodies

Share to HIV Infections

Share to Immunotherapy, Adoptive

Source

Identifiers

PMID: 32039686
DOI: 10.2174/1570162X18666200210121339

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Adeno-Associated Viral Vector Mediated Expression of Broadly- Neutralizing Antibodies Against HIV-Hitting a Fast-Moving Target.PMID 32039686Read ↗

Antibody gene transfer with adeno‐associated viral vectors as a method for HIV preventionSemantic proximity Read ↗

HIV broadly neutralizing antibody escape dynamics drive the outcome of AAV-vectored immunotherapy in humanized mice.Semantic proximity Read ↗

Adeno-Associated Virus Structural Biology as a Tool in Vector DevelopmentSemantic proximity Read ↗

HIV broadly neutralizing antibody escape dynamics drive the outcome of AAV vectored immunotherapy in humanized miceSemantic proximity Read ↗

Optimized and enhanced DNA plasmid vector based in vivo construction of a neutralizing anti-HIV-1 envelope glycoprotein FabSemantic proximity Read ↗

Recent Advancements in AAV-Vectored Immunoprophylaxis in the Nonhuman Primate ModelSemantic proximity Read ↗

Broadly Neutralizing Antibodies for HIV EradicationSemantic proximity Read ↗

Engineering HIV-Resistant, Anti-HIV Chimeric Antigen Receptor T CellsSemantic proximity Read ↗

Structure-guided evolution of antigenically distinct adeno-associated virus variants for immune evasionSemantic proximity Read ↗

HIV-1-Specific Chimeric Antigen Receptors Based on Broadly Neutralizing AntibodiesSemantic proximity Read ↗

Broadly Neutralizing Human Immunodeficiency Virus Type 1 Antibody Gene Transfer Protects Nonhuman Primates from Mucosal Simian-Human Immunodeficiency Virus InfectionSemantic proximity Read ↗

Vectored Immunotherapeutics for Infectious Diseases: Can rAAVs Be The Game Changers for Fighting Transmissible Pathogens?Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.